Digoxin use after diagnosis of prostate cancer and survival: a population‐based cohort study

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|25|9|1099-1103

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.25, Iss.9, 2016-09, pp. : 1099-1103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel use and cancer‐specific mortality: a population‐based cohort study of colorectal, breast and prostate cancer patients

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 8, 2015-08 ,pp. : 830-840

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population‐based case–control study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1187-1195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Presence and Number of Positive Surgical Margins after Radical Prostatectomy for Prostate Cancer: Effect on Oncological Outcome in a Population-Based Cohort

By  

Urologia Internationalis, Vol. 95, Iss. 4, 2015-0 ,pp. : 472-477

Karger

Access to resources Recommend Favorite

Risk of second primary tumors in men diagnosed with prostate cancer: A population‐based cohort study

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2735-2741

John Wiley & Sons Inc

Access to resources Recommend Favorite

All‐cause mortality following a cancer diagnosis amongst multiple sclerosis patients: a Swedish population‐based cohort study

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 7, 2015-07 ,pp. : 1074-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite